Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microparticle Coagulolytic Balance in Septic Shock
NCT02062970Unknown
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Feb 2014
- Primary completion
- Jan 2018
- Countries
- 1
01
Overview
Single-arm trial, sponsored by Assistance Publique-Hôpitaux de Marseille. Primary endpoint: Prognostic value of coagulolytic balance of MP on mortality at 36 months. Status: unknown.
Beyond the preview
Go deeper on NCT02062970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02062970.